The Last Word

Trulieve CEO ‘Not Concerned’ by DEA’s Middleman Role in Schedule III Order

Kim Rivers dives into the feds’ impending access to her company’s facilities and other treaty obligations, as well as 280E taxes, product development and scientific research.

New Era of Scaling a Cannabis Business Starts With Discipline, CEO Explains

TheraTrue CEO Chris Ras outlines the company’s focus in Ohio and Georgia, and its balanced approach geared toward new markets.

Curaleaf Plans to Expand Its Hemp Store Concept ‘Far and Wide’

Curaleaf

Boris Jordan, Curaleaf Chairman and CEO, provides a glimpse behind the curtain following the transition of one of Curaleaf’s 66 Florida cannabis dispensaries into its first store selling only hemp-derived products.

‘We’re Not Just Building a Company—We’re Shaping the Future of an Industry’

Gibran Washington, CEO of multistate operator Ethos Cannabis, shares his take and tips on developing strategic vision and operational excellence.

Is Trump Good for Cannabis? MariMed CEO Explains

Jon Levine, who also serves as the company’s president, goes into detail about a heads-down business approach that supersedes White House politics.

Cannabis Rescheduling Nearly ‘Done Deal,’ Story Cannabis CEO Says

Jason Vedadi, the former executive chairman for Harvest Health before its acquisition by Trulieve, talks exclusively with CBT on what he expects from federal rescheduling as the industry awaits the DEA’s final determination.

Cresco Labs Returns to 'Core' After Terminating Columbia Care Deal

A conversation with Greg Butler, the cannabis company’s new president, on how Cresco re-mapped its vision after the deal fell through and top goals for the year ahead.

‘Descheduling Would Not Be Utopia’

Shane Pennington of Porter Wright Morris & Arthur addresses some of the biggest questions and concerns surrounding cannabis rescheduling, including the role of the FDA and Big Pharma.

When Launching a Cultivation Business, ‘Be Your Most Convinced Champion’

Christina Betancourt Johnson, owner and CEO of Standard Wellness Maryland and Rooted Therapeutics, provides insight into how to successfully launch and operate a cannabis cultivation business, from securing a location to building relationships with dispensaries.

‘Successful in Any Environment’

Colin Kelley of Merida Capital Holdings shares insights into how cannabis businesses can shift from reacting to planning ahead to withstand volatile market conditions.

BeLeaf Medical's Jason Nelson Considers 2023 'A Year of Reconciliation'

While Nelson, CEO of vertically integrated BeLeaf Medical, is optimistic about Missouri's sales growth and the state's strong adult-use launch, he’s taking a cautious approach.

TerrAscend’s New CEO on NJ Prospects

Ziad Ghanem, who recently took control of the company’s chief executive reins, outlines opportunities ahead in New Jersey.

Page 1 of 4

Next Page